EECP (Enhanced External Counterpulsation) therapy, also known as angiogenesis therapy, is a clinically validated non-invasive cardiovascular adjunctive treatment technique. The system is computer-controlled and applies rhythmic pressure through inflatable cuffs installed on the patient's lower limbs, synchronized with the cardiac cycle. During the diastolic phase (relaxation phase) of the heart, the cuffs sequentially inflate from the calves to the thighs, applying pressure that promotes the retrograde flow of arterial blood back to the heart, thereby increasing diastolic pressure and significantly enhancing coronary perfusion. This alteration in blood flow dynamics promotes angiogenesis, improves vascular elasticity and function, and contributes to overall cardiovascular efficiency. As cardiac function strengthens, blood circulation to the entire body also improves, particularly benefiting the brain and urogenital systems. For patients suffering from angina, myocardial ischemia, or heart failure, EECP is a safe, non-invasive alternative treatment option that provides a more comprehensive cardiovascular care solution.

Principles and Applications of EECP Therapy
Enhanced External Counterpulsation (EECP) is a non-invasive cardiovascular adjunctive treatment technique that promotes coronary perfusion and the establishment of collateral circulation during the diastolic phase of the heart through synchronized pneumatic pressure control with the cardiac cycle. During the systolic phase, the pressure is rapidly released, effectively reducing the cardiac load and achieving a "massage effect" on the blood vessels.

During the treatment process, patients lie flat on a specialized treatment bed with their legs wrapped in pneumatic cuffs. When the heart enters the diastolic phase, the cuffs sequentially inflate from the calves to the thighs, pushing blood back toward the central axis, which increases blood flow to the heart and vital organs. As the heart enters the systolic phase, the cuffs rapidly deflate, reducing resistance to blood return, alleviating cardiac workload, and enhancing blood circulation efficiency. This rhythmic compression and relaxation not only help improve myocardial ischemia but also promote systemic circulation and activate endothelial function.

Indications for EECP Therapy
EECP can be widely applied to various circulatory system-related diseases, providing effective non-pharmacological options, especially for middle-aged and elderly patients with chronic ischemic conditions:

Cardiovascular System: Stable angina, recovery after myocardial infarction, hypertension, hyperlipidemia, circulation regulation after stent placement, arterial stenosis or embolism.
Cerebrovascular System: Rehabilitation after ischemic stroke, neurodegenerative diseases such as Parkinson's disease, prevention of cerebral hypoperfusion.
Visceral and Metabolic Systems: Erectile dysfunction, renal insufficiency, inadequate intestinal blood flow, vascular complications due to diabetes, metabolic syndrome, difficulties in weight management.
Sensory Organ Ischemia-Related Issues: Ischemic optic neuropathy (blurred vision, macular degeneration), sudden hearing loss, dizziness, and other conditions related to inner ear blood flow abnormalities.